Drug Database
UR

Uralyt-K

✓ Approved

Rottapharm Madaus · Small Molecule · Small Molecule

What is Uralyt-K?

Uralyt-K is a small molecule developed by Rottapharm Madaus. It is approved for therapeutic indications via oral (po).

Drug Profile

CompanyRottapharm Madaus
Drug ClassSmall Molecule
RouteOral (PO)
StatusApproved

Therapeutic Indications

Uralyt-K is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Renal and urinary disordersCalculus urinary✓ Approved

Related Research Articles

PubMedAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-08-30

Synergistic Grain Boundary and Phonon Engineering Enables Ultrahigh Thermoelectric Performance in Mg3(Sb, Bi)2-Based Materials.

Lei Jingdan J, Xu Kai K, Zhao Kunpeng K, Zhou Junzhuo J et al.

Thermoelectric Mg3(Sb, Bi)2 has emerged as a rising star in virtue of its promising thermoelectric performance and abundant constituent elements. However, its practical application is hindered by challenges in synthesis and the strong coupling between electrical and thermal transport properties. Herein, we propose a dual-pronged strategy that combines grain boundary engineering and phonon engineering to decouple electron and phonon transport in Mg3(Sb, Bi)2. By employing a tantalum-tube encapsulated melting technique together with Cu doping, the grain size is markedly increased to ∼25 µm, effectively suppressing carrier grain boundary scattering and enabling single-crystal-like electrical transport with a high carrier mobility exceeding 200 cm2 V-1 s-1. Meanwhile, atomic-scale alloy disorder and nanoscale Mg2Cu precipitates introduce strong phonon scattering, leading to an ultralow lattice thermal conductivity of 0.36 W m-1 K-1. Eventually, a peak zT of 1.9 at 750 K and a high conversion efficiency of 10.6% at ΔT = 488 K are achieved, demonstrating the competitive performance of these materials and devices. This study not only provides new insights into the manipulation of grain boundary scattering, but also demonstrates the great promise of Mg3(Sb, Bi)2 for waste-heat harvesting.

PubMedMarine life science & technology2026-08-30

Paralemnanoids A-K, new norsesquiterpenoids and sesquiterpenoids with hepatoprotective activity from the soft coral Paralemnalia sp.

Pei Yanfang Y, Zong Yuan Y, Xu Jixiang J, Hou Huiyue H et al.

Eleven nardosinane-type compounds, including a norsesquiterpenoid featuring a novel carbon skeleton designated as paralemnanoid A (1), and ten additional norsesquiterpenoids identified as paralemnanoids B - K (2 - 11), were isolated from the South China Sea soft coral Paralemnalia sp.. Comprehensive structural elucidation of compounds 1 - 11 was achieved through an integrated analytical approach, combining including NMR spectroscopy, HRESIMS, single-crystal X-ray diffraction analysis, DP4 + probability assessments, ECD calculations, and literature comparisons. Furthermore, we proposed that the novel poly-isoprenoid scaffold paralemnanoid A (1) originates from paralemnanoid B (2) through sequential oxidative modifications followed by non-enzymatic skeletal rearrangements. The hepatoprotective effects of compounds 1 - 11 were assessed through bioassays, revealing that paralemnanoids A (1) and E (5) exhibited moderate hepatoprotective activity at a concentration of 20 μmol/L in the zebrafish model. This study expands the chemical diversity of marine-derived nardosinane-type terpenoids and provides new insights into their potential therapeutic applications. The online version contains supplementary material available at https://doi.org/10.1007/s42995-025-00339-0.

PubMedJapanese journal of infectious diseases2026-08-30

Superior in vitro Activity of Cefepime-Enmetazobactam Over Ceftazidime-Avibactam and Piperacillin-Tazobactam Against 3rd Generation cephalosporin resistant Enterobacterales.

Aggarwal Prabhav P, Saxena Sonal S, Amritha Anugula A, Kaim Manisha M

The rise of extended-spectrum β-lactamase (ESBL) and carbapenem-resistant Enterobacterales (CRE) has severely limited treatment options in India. Cefepime-enmetazobactam (FPE), a novel β-lactam/β-lactamase inhibitor combination approved by the US FDA in 2024, shows promise as a carbapenem-sparing agent. A total of 383 non-duplicate resistant isolates of Escherichia coli and Klebsiella pneumoniae subsp. pneumoniae. were studied (January 2023-December 2024) at a tertiary-care centre in New Delhi. Isolates were categorized as third generation cephalosporin resistant but carbapenem-susceptible (Group A, n=258) or carbapenem-resistant (Group B, n=125). Antimicrobial susceptibility was determined by CLSI disc diffusion, and synergy with aztreonam was evaluated. Among Group A isolates, FPE exhibited the highest activity-95.4% E. coli and 97.4% K. pneumoniae susceptibility-outperforming ceftazidime-avibactam (88.1% and 84.6%) and Piperacillin tazobactam (5.4% and 10.2%, respectively). In Group B (CRE), activity was significantly lower: FPE (13% E. coli, 14.3% K. pneumoniae), CZA (31.9% and 7.1%), and PT (0%). ESBL production was observed in 88% of Group A isolates, predominantly blaCTX-M (94%), while all CRE carried blaNDM and blaOXA-48 genes. FPE-aztreonam synergy was infrequent (≤4%). Cefepime-enmetazobactam demonstrated superior in vitro activity to CZA and Piperacillin Tazobactam against ESBL-producing but carbapenem-susceptible Enterobacterales, making it a potent carbapenem-sparing option.

PubMedBiological & pharmaceutical bulletin2026-08-30

Pharmacological Blockade of Aquaporin-4 Attenuates Na+/K+-ATPase Dysfunction-Induced Inner Retinal Injury in Rats.

Odaka Ryosuke R, Deguchi Saori S, Morita Akane A, Kashihara Toshihide T et al.

Diabetic retinopathy, a major cause of visual impairment, involves multiple pathological processes, including disruption of water homeostasis regulated by Müller glial cells. Aquaporin-4 (AQP4) is a water channel that mediates passive water transport driven by an osmotic gradient, whereas Na+/K+-ATPase (NKA) maintains the ionic balance underlying this process. We previously demonstrated that ouabain, an NKA inhibitor, preferentially induces neuronal cell loss in the inner retina. This study aimed to elucidate the role of AQP4 in ouabain-induced inner retinal injury using male Sprague-Dawley rats and rat retinal Müller cells (rMC-1). Immunohistochemical analysis revealed that AQP4 was localized to the endfeet of Müller cells along the deep retinal capillaries and was expressed throughout the cell body in rMC-1 cells. To assess the role of AQP4 in ouabain-induced retinal injury, we examined the effects of TGN020, an AQP4 inhibitor, using both in vitro and in vivo models. Ouabain induced acute cell swelling in rMC-1 cells, and this effect was significantly attenuated by TGN020 treatment. In vivo, rats were intravitreally injected with ouabain alone or in combination with TGN020, and retinal histological changes were evaluated 7 d after injection. Ouabain induced cell loss in both the ganglion cell layer (GCL) and inner nuclear layer (INL). Co-administration of TGN020 reduced cell loss in the INL, but not in the GCL. These findings suggest that the disruption of AQP4-mediated water transport in Müller cells may contribute to INL neurodegeneration associated with NKA dysfunction in rats.

PubMedAdsorption : journal of the International Adsorption Society2026-08-30

A reference low-pressure CO2 adsorption isotherm for zeolite 13X: results of an interlaboratory study.

Nguyen Huong Giang T HGT, Newton David D, Ahmad Riaz R, Prinz Carsten C et al.

This paper reports the results of an international interlaboratory study sponsored by the Versailles Project on Advanced Materials and Standards (VAMAS) and led by the National Institute of Standards and Technology (NIST) on the measurement of low-pressure CO2 adsorption isotherms at 25 °C on zeolite 13X (NIST research grade test material 10257). Eighteen laboratories participated in the study and contributed 21 datasets. From these data, a consensus reference isotherm, along with the 95% uncertainty interval (U k=2 ), were determined and reported. Results indicate the material is suitable for development into NIST reference material, which will become the first zeolitic reference material in beaded form at NIST. The online version contains supplementary material available at https://doi.org/10.1007/s10450-026-00701-3.

PubMedProgress in nuclear magnetic resonance spectroscopy2026-08-30

The Dissolution-Dynamic Nuclear Polarization Experiment.

Meier Benno B

Dissolution-Dynamic Nuclear Polarization (D-DNP) addresses the most pressing issue of nuclear magnetic resonance spectroscopy - low sensitivity. In D-DNP the analyte is mixed with a radical in a glass-forming matrix. This substrate is frozen and kept at low temperature (<100 K) and a magnetic field of several Tesla. By using microwave irradiation, polarization is transferred from electron spins to nuclear spins. The substrate is then liquefied, and the liquid-state signal of the nuclear spins is observed in a high-resolution nuclear magnetic resonance (NMR) magnet or a magnetic resonance imaging scanner. The D-DNP technique has enabled spectacular experiments, such as the in vivo observation of human metabolism. However, unlike other sensitivity enhancement methodologies, such as cryoprobes or magic angle spinning (MAS) DNP, D-DNP is not applied broadly in NMR spectroscopy at present. Here, we describe (i) the gains of an ideal D-DNP experiment for NMR spectroscopy, and contrast them with the real implementations of the D-DNP experiment available today, with a focus on applications in spectroscopy. We review principles of (ii) the dynamic nuclear polarization step and (iii) the sample transfer. We argue (iv) that stringent automation is essential for broader adaptation of the D-DNP experiment.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about Uralyt-K